Inhibitory effects of piceatannol on human cytomegalovirus (hCMV) in vitro. 2020

San-Ying Wang, and Jing Zhang, and Xiao-Gang Xu, and Hui-Li Su, and Wen-Min Xing, and Zhong-Shan Zhang, and Wei-Hua Jin, and Ji-Huan Dai, and Ya-Zhen Wang, and Xin-Yue He, and Chuan Sun, and Jing Yan, and Gen-Xiang Mao
Zhejiang Provincial Key Lab of Geriatrics & Geriatrics Institute of Zhejiang Province, Department of Geriatrics, Zhejiang Hospital, Hangzhou, 310030, P. R. China.

Human cytomegalovirus (hCMV) is a ubiquitous herpesvirus, which results in the establishment of a latent infection that persists throughout the life of the host and can be reactivated when the immunity is low. Currently, there is no vaccine for hCMV infection, and the licensed antiviral drugs mainly target the viral enzymes and have obvious adverse reactions. Thus, it is important to search for compounds with anti-hCMV properties. The present study aimed to investigate the suppressive effects of piceatannol on hCMV Towne strain infection and the putative underlying mechanisms using human diploid fibroblast WI-38 cells. Piceatannol supplementation prevented the lytic changes induced by hCMV infection in WI-38 cells. Furthermore, piceatannol suppressed the expression of hCMV immediate-early (IE) and early (E) proteins as well as the replication of hCMV DNA in a dose-dependent manner. Moreover, hCMV-induced cellular senescence was suppressed by piceatannol, as shown by a decline in the senescence-associated β-galactosidase (SA-β-Gal) activity and decreased production of intracellular reactive oxygen species (ROS). p16INK4a, a major senescence-associated molecule, was dramatically elevated by current hCMV infection that was attenuated by pre-incubation with piceatannol in a dose-dependent manner. These results demonstrated that piceatannol suppressed the hCMV infection via inhibition of the activation of p16INK4a and cellular senescence induced by hCMV. Together, these findings indicate piceatannol as a novel and potent anti-hCMV agent with the potential to be developed as an effective treatment for chronic hCMV infection.

UI MeSH Term Description Entries
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D003586 Cytomegalovirus Infections Infection with CYTOMEGALOVIRUS, characterized by enlarged cells bearing intranuclear inclusions. Infection may be in almost any organ, but the salivary glands are the most common site in children, as are the lungs in adults. CMV Inclusion,CMV Inclusions,Congenital CMV Infection,Congenital Cytomegalovirus Infection,Cytomegalic Inclusion Disease,Cytomegalovirus Colitis,Cytomegalovirus Inclusion,Cytomegalovirus Inclusion Disease,Cytomegalovirus Inclusions,Inclusion Disease,Perinatal CMV Infection,Perinatal Cytomegalovirus Infection,Renal Tubular Cytomegalovirus Inclusion,Renal Tubular Cytomegalovirus Inclusions,Salivary Gland Virus Disease,Severe Cytomegalovirus Infection,Severe Cytomegalovirus Infections,Infections, Cytomegalovirus,CMV Infection, Congenital,CMV Infection, Perinatal,Colitis, Cytomegalovirus,Congenital CMV Infections,Congenital Cytomegalovirus Infections,Cytomegalic Inclusion Diseases,Cytomegalovirus Colitides,Cytomegalovirus Inclusion Diseases,Cytomegalovirus Infection,Cytomegalovirus Infection, Congenital,Cytomegalovirus Infection, Perinatal,Cytomegalovirus Infection, Severe,Cytomegalovirus Infections, Severe,Disease, Cytomegalic Inclusion,Disease, Cytomegalovirus Inclusion,Diseases, Cytomegalovirus Inclusion,Inclusion Disease, Cytomegalic,Inclusion Disease, Cytomegalovirus,Inclusion Diseases,Inclusion Diseases, Cytomegalovirus,Inclusion, CMV,Inclusion, Cytomegalovirus,Infection, Congenital CMV,Infection, Congenital Cytomegalovirus,Infection, Cytomegalovirus,Infection, Perinatal CMV,Infection, Perinatal Cytomegalovirus,Infection, Severe Cytomegalovirus,Perinatal CMV Infections,Perinatal Cytomegalovirus Infections
D003587 Cytomegalovirus A genus of the family HERPESVIRIDAE, subfamily BETAHERPESVIRINAE, infecting the salivary glands, liver, spleen, lungs, eyes, and other organs, in which they produce characteristically enlarged cells with intranuclear inclusions. Infection with Cytomegalovirus is also seen as an opportunistic infection in AIDS. Herpesvirus 5, Human,Human Herpesvirus 5,Salivary Gland Viruses,HHV 5,Herpesvirus 5 (beta), Human,Cytomegaloviruses,Salivary Gland Virus,Virus, Salivary Gland,Viruses, Salivary Gland
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D001616 beta-Galactosidase A group of enzymes that catalyzes the hydrolysis of terminal, non-reducing beta-D-galactose residues in beta-galactosides. Deficiency of beta-Galactosidase A1 may cause GANGLIOSIDOSIS, GM1. Lactases,Dairyaid,Lactaid,Lactogest,Lactrase,beta-D-Galactosidase,beta-Galactosidase A1,beta-Galactosidase A2,beta-Galactosidase A3,beta-Galactosidases,lac Z Protein,Protein, lac Z,beta D Galactosidase,beta Galactosidase,beta Galactosidase A1,beta Galactosidase A2,beta Galactosidase A3,beta Galactosidases
D013267 Stilbenes Organic compounds that contain 1,2-diphenylethylene as a functional group. Stilbene,Stilbene Derivative,Stilbene Derivatives,Stilbenoid,Stilbenoids,Derivative, Stilbene,Derivatives, Stilbene
D014779 Virus Replication The process of intracellular viral multiplication, consisting of the synthesis of PROTEINS; NUCLEIC ACIDS; and sometimes LIPIDS, and their assembly into a new infectious particle. Viral Replication,Replication, Viral,Replication, Virus,Replications, Viral,Replications, Virus,Viral Replications,Virus Replications
D016922 Cellular Senescence Process by which cells irreversibly stop dividing and enter a state of permanent growth arrest without undergoing CELL DEATH. Senescence can be induced by DNA DAMAGE or other cellular stresses, such as OXIDATIVE STRESS. Aging, Cell,Cell Aging,Cell Senescence,Replicative Senescence,Senescence, Cellular,Senescence, Replicative,Cell Ageing,Cellular Ageing,Cellular Aging,Ageing, Cell,Ageing, Cellular,Aging, Cellular,Senescence, Cell
D017382 Reactive Oxygen Species Molecules or ions formed by the incomplete one-electron reduction of oxygen. These reactive oxygen intermediates include SINGLET OXYGEN; SUPEROXIDES; PEROXIDES; HYDROXYL RADICAL; and HYPOCHLOROUS ACID. They contribute to the microbicidal activity of PHAGOCYTES, regulation of SIGNAL TRANSDUCTION and GENE EXPRESSION, and the oxidative damage to NUCLEIC ACIDS; PROTEINS; and LIPIDS. Active Oxygen Species,Oxygen Radical,Oxygen Radicals,Pro-Oxidant,Reactive Oxygen Intermediates,Active Oxygen,Oxygen Species, Reactive,Pro-Oxidants,Oxygen, Active,Pro Oxidant,Pro Oxidants,Radical, Oxygen

Related Publications

San-Ying Wang, and Jing Zhang, and Xiao-Gang Xu, and Hui-Li Su, and Wen-Min Xing, and Zhong-Shan Zhang, and Wei-Hua Jin, and Ji-Huan Dai, and Ya-Zhen Wang, and Xin-Yue He, and Chuan Sun, and Jing Yan, and Gen-Xiang Mao
July 1999, Ceska a slovenska oftalmologie : casopis Ceske oftalmologicke spolecnosti a Slovenske oftalmologicke spolecnosti,
San-Ying Wang, and Jing Zhang, and Xiao-Gang Xu, and Hui-Li Su, and Wen-Min Xing, and Zhong-Shan Zhang, and Wei-Hua Jin, and Ji-Huan Dai, and Ya-Zhen Wang, and Xin-Yue He, and Chuan Sun, and Jing Yan, and Gen-Xiang Mao
June 1999, Zhonghua shi yan he lin chuang bing du xue za zhi = Zhonghua shiyan he linchuang bingduxue zazhi = Chinese journal of experimental and clinical virology,
San-Ying Wang, and Jing Zhang, and Xiao-Gang Xu, and Hui-Li Su, and Wen-Min Xing, and Zhong-Shan Zhang, and Wei-Hua Jin, and Ji-Huan Dai, and Ya-Zhen Wang, and Xin-Yue He, and Chuan Sun, and Jing Yan, and Gen-Xiang Mao
January 2010, Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie,
San-Ying Wang, and Jing Zhang, and Xiao-Gang Xu, and Hui-Li Su, and Wen-Min Xing, and Zhong-Shan Zhang, and Wei-Hua Jin, and Ji-Huan Dai, and Ya-Zhen Wang, and Xin-Yue He, and Chuan Sun, and Jing Yan, and Gen-Xiang Mao
October 1987, Journal of medical virology,
San-Ying Wang, and Jing Zhang, and Xiao-Gang Xu, and Hui-Li Su, and Wen-Min Xing, and Zhong-Shan Zhang, and Wei-Hua Jin, and Ji-Huan Dai, and Ya-Zhen Wang, and Xin-Yue He, and Chuan Sun, and Jing Yan, and Gen-Xiang Mao
December 2004, Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi,
San-Ying Wang, and Jing Zhang, and Xiao-Gang Xu, and Hui-Li Su, and Wen-Min Xing, and Zhong-Shan Zhang, and Wei-Hua Jin, and Ji-Huan Dai, and Ya-Zhen Wang, and Xin-Yue He, and Chuan Sun, and Jing Yan, and Gen-Xiang Mao
October 2004, Journal of virology,
San-Ying Wang, and Jing Zhang, and Xiao-Gang Xu, and Hui-Li Su, and Wen-Min Xing, and Zhong-Shan Zhang, and Wei-Hua Jin, and Ji-Huan Dai, and Ya-Zhen Wang, and Xin-Yue He, and Chuan Sun, and Jing Yan, and Gen-Xiang Mao
May 2003, The Journal of antimicrobial chemotherapy,
San-Ying Wang, and Jing Zhang, and Xiao-Gang Xu, and Hui-Li Su, and Wen-Min Xing, and Zhong-Shan Zhang, and Wei-Hua Jin, and Ji-Huan Dai, and Ya-Zhen Wang, and Xin-Yue He, and Chuan Sun, and Jing Yan, and Gen-Xiang Mao
March 2014, Early human development,
San-Ying Wang, and Jing Zhang, and Xiao-Gang Xu, and Hui-Li Su, and Wen-Min Xing, and Zhong-Shan Zhang, and Wei-Hua Jin, and Ji-Huan Dai, and Ya-Zhen Wang, and Xin-Yue He, and Chuan Sun, and Jing Yan, and Gen-Xiang Mao
January 2017, Deutsches Arzteblatt international,
San-Ying Wang, and Jing Zhang, and Xiao-Gang Xu, and Hui-Li Su, and Wen-Min Xing, and Zhong-Shan Zhang, and Wei-Hua Jin, and Ji-Huan Dai, and Ya-Zhen Wang, and Xin-Yue He, and Chuan Sun, and Jing Yan, and Gen-Xiang Mao
January 2020, Acta virologica,
Copied contents to your clipboard!